Form 4: Korro Bio Insider Boosts Stake with $2.3M Stock, Warrants

Forest Baskett, a director and 10% owner of Korro Bio, Inc., acquired over 440,000 shares and pre-funded warrants in a recent transaction.

Summary

• Forest Baskett, a Director and 10% Owner of Korro Bio, Inc. (KRRO), acquired additional securities on March 10, 2026.
• The acquisition included 207,100 shares of Common Stock at $11.11 per share, totaling approximately $2,300,881.
• Baskett also acquired 242,945 Pre-Funded Warrants with an exercise price of $0.001, underlying 242,945 shares of Common Stock, at an acquisition price of $11.109 per warrant, totaling approximately $2,698,395.
• These transactions were executed pursuant to a Subscription Agreement dated March 9, 2026.
• Following the acquisitions, the indirect beneficial ownership of Common Stock by NEA 17 (through which Baskett has an interest) is 1,297,893 shares, and 242,945 Pre-Funded Warrants.
• The Pre-Funded Warrants are immediately exercisable, subject to a 9.99% ownership limitation, which can be increased to 19.99% with 61 days' prior notice.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. Insider buying, especially by a director and 10% owner, typically indicates confidence in the company's future, though the specific financial impact depends on the overall capital structure and market conditions.

Positives

• A director and significant owner increasing their stake can signal strong confidence in the company's future prospects and valuation.
• The acquisition of pre-funded warrants provides flexibility for future equity conversion, allowing the investor to increase their stake further.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-planned acquisition strategy rather than an opportunistic one.

Risks

• The 9.99% ownership cap on warrant exercise, while adjustable, could limit the immediate full conversion of warrants, potentially impacting the holder's ability to fully realize their stake quickly if desired.

Future Outlook

A Form 4 filing does not typically contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider purchases, especially by directors and significant shareholders, are often viewed positively by the market as they can signal strong internal confidence in the company's valuation and future prospects. This transaction by a 10% owner and director in Korro Bio, a biotechnology company, could be interpreted as a bullish signal, particularly in a sector often characterized by high risk and high reward.

Comparison to Industry Standards

• Insider buying is a common occurrence across all industries and is generally seen as a positive indicator.
• The acquisition of additional equity and warrants by a director and 10% owner aligns with similar actions by insiders in other growth-oriented sectors, including biotech, where management's belief in future drug pipelines or technology advancements is crucial.

Related Party Transactions

• The acquisition of securities by Forest Baskett, a Director and 10% Owner, from the Issuer (Korro Bio, Inc.) constitutes a related party transaction.
• The transaction was conducted pursuant to a Subscription Agreement dated March 9, 2026.
• The reporting person's indirect beneficial ownership is through entities (NEA 17 GP, LLC, NEA Partners 17, L.P., New Enterprise Associates 17, L.P.) where he is a manager, further solidifying the related party nature.

Stakeholder Impact

• Shareholders: The capital raise through the issuance of new shares and warrants could lead to minor dilution for existing shareholders, but the insider's increased stake may also boost investor confidence.
• Company (Korro Bio, Inc.): Receives capital infusion from the sale of common stock and pre-funded warrants, strengthening its financial position.

Next Steps

• The Pre-Funded Warrants are exercisable at any time after their issuance, subject to ownership limitations.
• The holder has the option to increase or decrease the 9.99% ownership cap on warrant exercise upon 61 days' prior notice to the Issuer, not to exceed 19.99%.

Key Dates

Recommendation

The acquisition by a director and 10% owner signals internal confidence, which is a positive indicator. However, this filing is a transactional report and does not provide a full financial picture or strategic update. A seasoned investor would view this as a supportive data point but would require a deeper dive into Korro Bio's financial statements, pipeline progress, and market position before making a stronger recommendation. Therefore, maintaining a 'hold' position while awaiting more comprehensive information is prudent.

Keywords

Korro Bio, KRRO, Forest Baskett, insider trading, Form 4, beneficial ownership, common stock, pre-funded warrants, equity acquisition, director, 10% owner, NEA 17